Cargando…

Safety of Rifabutin in patients with rifampicin-induced thrombocytopenia

Detalles Bibliográficos
Autores principales:	Sarkar, Trina, Riccardi, Niccolò, Wagh, Haresh, Udwadia, Zarir F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857375/ https://www.ncbi.nlm.nih.gov/pubmed/32883912 http://dx.doi.org/10.4103/lungindia.lungindia_401_20

Ejemplares similares

Use of nintedanib in patients with idiopathic pulmonary fibrosis: Initial Indian experience
por: Mullerpattan, Jai B, et al.
Publicado: (2019)

Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?
por: Schmaltz, Carolina Arana Stanis, et al.
Publicado: (2019)

Thrombocytopenia due to rifampicin
por: Dixit, Ramakant, et al.
Publicado: (2012)

Thrombocytopenia due to rifampicin
por: Gupta, Prahlad Rai
Publicado: (2012)

Rifampicin-induced thrombocytopenia
por: Verma, Ajay Kumar, et al.
Publicado: (2010)

Isoniazid- and rifampicin-induced thrombocytopenia
por: Yakar, Fatih, et al.
Publicado: (2013)

Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavir
por: Moultrie, Harry, et al.
Publicado: (2015)

Comprehensive in vitro analysis evaluating the variable drug–drug interaction risk of rifampicin compared to rifabutin
por: Nilles, Julie, et al.
Publicado: (2023)

Recurrent neutropenia induced by rifabutin in a renal transplant recipient
por: Chang, Ji Yeun, et al.
Publicado: (2014)

Therapeutic Trial of Rifabutin After Rifampicin-Associated DRESS Syndrome in Tuberculosis-Human Immunodeficiency Virus Coinfected Patients
por: Lehloenya, Rannakoe J., et al.
Publicado: (2016)

Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency
por: Anthony, Richard M, et al.
Publicado: (2005)

Rifabutin induced hypopyon uveitis mimicking endophthalmitis as a manifestation of IRU in patients with HIV
por: Nair, Nivedita, et al.
Publicado: (2022)

Comments regarding use of rifabutin for Helicobacter pylori eradication
por: Graham, David Y.
Publicado: (2021)

Why “covering all” in the DOTS program is not necessarily “all being covered” by the DOTS program
por: Pinto, Lancelot Mark, et al.
Publicado: (2010)

Severe interstitial lung disease persisting 2 years post-COVID-19 despite anti-fibrotic therapy
por: Udwadia, Zarir F., et al.
Publicado: (2022)

Effective use of telemedicine in Mumbai with a cohort of extensively drug-resistant “XDR” tuberculosis patients on bedaquiline during COVID-19 pandemic
por: Udwadia, Zarir F., et al.
Publicado: (2021)

Swimming against the STREAM: Why STREAM 2 data cannot be easily applied to MDR-TB patients across India
por: Udwadia, Zarir F., et al.
Publicado: (2023)

A case of thrombocytopenia caused by rifampicin and pyrazinamide
por: Bansal, Rekha, et al.
Publicado: (2013)

Response to the comments received on article “Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial” by Udwadia et al
por: Udwadia, Zarir F., et al.
Publicado: (2021)

Private patient perceptions about a public programme; what do private Indian tuberculosis patients really feel about directly observed treatment?
por: Pinto, Lancelot M, et al.
Publicado: (2010)

Oxaliplatin-induced lung fibrosis
por: Shah, Arpan, et al.
Publicado: (2009)

In Vitro Synergy Testing of Eravacycline in Combination with Clarithromycin and Rifabutin against Mycobacterium abscessus Complex
por: Chew, Ka Lip, et al.
Publicado: (2021)

Comparative analysis of the drug-drug interaction between immunosuppressants, safety and efficacy of rifabutin from rifampicin-based Anti-TB treatment in living donor liver transplant recipients with active tuberculosis
por: Wang, Yu-Chen, et al.
Publicado: (2021)

A case of severe thrombocytopenia after the first exposure to rifampicin
por: Nakane, Chinatsu, et al.
Publicado: (2023)

Disseminated tuberculosis with immune thrombocytopenic purpura
por: Dagaonkar, Rucha S., et al.
Publicado: (2012)

Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai
por: Udwadia, Zarir F., et al.
Publicado: (2014)

India should speed up access to bedaquiline-based all-oral regimens, not procrastinate further
por: Udwadia, Zarir F, et al.
Publicado: (2021)

Tropical pulmonary eosinophilia - A review
por: Mullerpattan, Jai B., et al.
Publicado: (2013)

Rifabutin Is Active against Mycobacterium abscessus in Mice
por: Dick, Thomas, et al.
Publicado: (2020)

Rifabutin Is Active against Mycobacterium abscessus Complex
por: Aziz, Dinah Binte, et al.
Publicado: (2017)

Cost-Effectiveness of Vonoprazan- and Rifabutin-Based Regimens
por: Almenoff, June
Publicado: (2023)

Quality of drug-resistant tuberculosis care: Gaps and solutions
por: Udwadia, Zarir, et al.
Publicado: (2019)

Ex Vivo Human Placental Transfer of Rifampin and Rifabutin
por: Magee, Kevin P., et al.
Publicado: (1996)

In vitro activity of rifabutin against 293 contemporary carbapenem-resistant Acinetobacter baumannii clinical isolates and characterization of rifabutin mode of action and resistance mechanisms
por: Trebosc, Vincent, et al.
Publicado: (2020)

The N-95 mask: Invaluable ally in the battle against the COVID-19 pandemic
por: Udwadia, Zarir F., et al.
Publicado: (2020)

How to protect the protectors: 10 lessons to learn for doctors fighting the COVID-19 coronavirus
por: Udwadia, Zarir F., et al.
Publicado: (2020)

New treatments for Drug Resistant TB: Past imperfect, future bright
por: Udwadia, Zarir F., et al.
Publicado: (2023)

Pharmacokinetics of Rifabutin in Japanese HIV-Infected Patients with or without Antiretroviral Therapy
por: Tanuma, Junko, et al.
Publicado: (2013)

Effect of rifampicin and erythromycin on the initiation of galactose induced cataract in rats
por: Patil, Raj Rajeshwari R., et al.
Publicado: (2012)

Rifabutin for the Treatment of Helicobacter pylori Infection: A Review
por: Gisbert, Javier P.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ebegshsr1rdfi5m6qktbpfh704